From owner-diagnost@hgmp.mrc.ac.uk Mon Sep 11 09:59:54 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id E40E917B0C; Mon, 11 Sep 2000 09:59:53 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id A49E317B0E; Mon, 11 Sep 2000 09:59:52 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@slb3.atl.mindspring.net, [mailto:news@slb3.atl.mindspring.net]@hgmp.mrc.ac.uk Subject: http://www.neuroprosthesis.org Message-Id: <20000911085952.A49E317B0E@mercury.hgmp.mrc.ac.uk> Date: Mon, 11 Sep 2000 09:59:52 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hi, I would like to announce a new Web site, http://www.neuroprosthesis.org, which might be interesting to readers of this newsgroup. As the name suggests, it is concerned with brain computer interaction, sensory-motor substitution, microsensor implants, and biomorphic robotics. Please visit us and share your opinion with us related to this subject. Thanks a lot, Gyongyi Gaal From owner-diagnost@hgmp.mrc.ac.uk Thu Sep 21 14:38:31 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 31DAA17AAD; Thu, 21 Sep 2000 14:38:31 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id C252F17BDE; Thu, 21 Sep 2000 14:38:29 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@aida.med.teikyo-u.ac.jp, [mailto:news@aida.med.teikyo-u.ac.jp]@hgmp.mrc.ac.uk Subject: anti-human nestin parimary antibody Message-Id: <20000921133829.C252F17BDE@mercury.hgmp.mrc.ac.uk> Date: Thu, 21 Sep 2000 14:38:29 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Greetings, I need help to locate preferably commercial supplier/suppliers of primary antibody for human nestin. Thanks in advance, Yasuo -- ((( Yasuo Tajima O-O tajima@mcn.ne.jp ~ From owner-diagnost@hgmp.mrc.ac.uk Tue Sep 26 09:10:01 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 148F617A89; Tue, 26 Sep 2000 09:09:59 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id F352417B34; Tue, 26 Sep 2000 09:09:58 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: Req: Please identify this substance ! Message-Id: <20000926080958.F352417B34@mercury.hgmp.mrc.ac.uk> Date: Tue, 26 Sep 2000 09:09:58 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hi I'm an anesthetist from the UK. Following a problem with a piece of apparatus attatched to the patient's breathing system, I took a sample and got the hospital lab to run it through a mass spectrometer to check for contaminants. A peak was found of: 1,2 Benzenedicarboxylic Acid, diisooctyl ester I can't find any information about this substance. I suspect it may be a component of: a) lung surfactant or b) mucus from the patients lungs Could I be correct ? I'd be very grateful if you could e mail me with any information regarding this compound. Many thanks in anticipation David Williams FRCA --- From owner-diagnost@hgmp.mrc.ac.uk Tue Sep 26 09:15:26 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id 9AD8B17B3E; Tue, 26 Sep 2000 09:15:24 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 30E6517B3E; Tue, 26 Sep 2000 09:15:22 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: nobody@hgmp.mrc.ac.uk, [mailto:nobody@hgmp.mrc.ac.uk]@hgmp.mrc.ac.uk, On@hgmp.mrc.ac.uk, Behalf@hgmp.mrc.ac.uk, Of@hgmp.mrc.ac.uk Subject: BCR/ABL fusion genes Message-Id: <20000926081522.30E6517B3E@mercury.hgmp.mrc.ac.uk> Date: Tue, 26 Sep 2000 09:15:22 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Hi there We have a patient who has both the p210 BcrAbl B3A2 and B2A2 fusion transcripts. I would like to find some literature on this could anyone suggest a paper or some experience of this?? thanks Louise This email or attachment(s) may contain confidential or legally privileged information intended for the sole use of the addressee(s). Any use, redistribution, disclosure, or reproduction of this message, except as intended, is prohibited. If you received this email in error, please notify the sender and remove all copies of the message, including any attachments. Any views or opinions expressed in this email (unless otherwise stated) may not represent those of Canterbury Health Ltd. --- From owner-diagnost@hgmp.mrc.ac.uk Wed Sep 27 09:19:34 2000 Return-Path: Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110) id A232C17AE4; Wed, 27 Sep 2000 09:19:33 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 5F24A17AE4; Wed, 27 Sep 2000 09:19:31 +0100 (BST) To: diagnost@net.bio.net Newsgroups: bionet.diagnostics From: news@aida.med.teikyo-u.ac.jp, [mailto:news@aida.med.teikyo-u.ac.jp]@hgmp.mrc.ac.uk Subject: human nestin antibody for immunohistochemistry Message-Id: <20000927081931.5F24A17AE4@mercury.hgmp.mrc.ac.uk> Date: Wed, 27 Sep 2000 09:19:31 +0100 (BST) Sender: owner-diagnost@hgmp.mrc.ac.uk Precedence: bulk Greetings, I'm currently setting up a project that will involve the usage of the anti-human nestin antibody for immunohistochemistry but so far I haven't been able to locate a supplier. Could anyone help me with this? I'd appreciate it very much. Best, Yasuo